Di-t-butyl-n-propylphosphin | 32376-19-5

• 分子结构分类: 有机化合物 - 有机磷化合物 - 有机膦及其衍生物
• 英文名称: Di-t-butyl-n-propylphosphin
• 英文别名: n-Propyl-di-tert.-butyl-phosphin；PPr(n)Bu(t)2；di-tert-butyl-n-propylphosphine；Di-t-butyl(propyl)phosphine；ditert-butyl(propyl)phosphane
• CAS: 32376-19-5
• 化学式: C₁₁H₂₅P
• 分子量: 188.293
• InChiKey: BUIWDQCNBLEZFU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为反应物：
  描述：

  氯化铑(三水) 、 Di-t-butyl-n-propylphosphin 以 水 、 异丙醇 为溶剂， 生成 Rhodium, bis[bis(1,1-dimethylethyl)propylphosphine]dichlorohydro-
  参考文献：
  名称：

  一些新颖的配合物，包括由三氯化铑和叔叔丁基膦形成的非常活泼的加氢催化剂

  摘要：

  由叔丁基膦和铑制备了反式-[RhCl 2 L 2 ]，[Rh-HCl 2 L 2 ]，[RhH 2 CIL 2 ]和反式-[RhCl（CO）L 2 ]类型的配合物三氯化物 一些配合物是非常活泼的加氢催化剂。

  DOI：

  10.1039/c29710000210

文献信息

• PROCESS FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE THROUGH COUPLING USING TRANSITION METAL CATALYST
  申请人：Komiyama Masato

  公开号：US20110313169A1

  公开（公告）日：2011-12-22

  A process for efficiently producing, through few steps either a xanthine oxidase inhibitor, which is a therapeutic agent for hyperuricemia, or an intermediate therefore. The process is a novel coupling process which comprises subjecting a compound represented by formula (1) to coupling reaction with a compound represented by formula (2) in the presence of a transition metal compound to thereby obtain a compound represented by formula (3).

  一种高效生产黄嘌呤氧化酶抑制剂或其中间体的方法，该抑制剂是治疗高尿酸血症的药物。该方法是一种新型偶联过程，包括将式（1）表示的化合物与式（2）表示的化合物在过渡金属化合物存在下进行偶联反应，从而获得式（3）表示的化合物。
• DYE, PHOTOELECTRIC CONVERSION ELEMENT USING THE SAME, PHOTOELECTROCHEMICAL CELL, AND METHOD OF PRODUCING DYE
  申请人：Kobayashi Katsumi

  公开号：US20110213144A1

  公开（公告）日：2011-09-01

  A dye, having a structure represented by formula (1A): wherein A represents a group of atoms necessary for forming a ring together with the carbon-nitrogen bond; at least one of Y 1A and Y 2A represents an acidic group, in which when they each represent an acidic group, they may be the same as or different from each other, or when only one of them represents an acidic group, the other represents an electron-withdrawing group; D represents a group to give a dye; n represents an integer of 1 or greater; L represents a single bond or a divalent linking group; and Y 3A represents an acidic group.

  一种染料，其结构由式（1A）表示：其中A代表与碳-氮键一起形成环的原子团；Y1A和Y2A中至少一个代表酸性基团，当它们各自代表酸性基团时，它们可以相同也可以不同，或者当它们中只有一个代表酸性基团时，另一个代表电子吸引基团；D代表给染料的基团；n代表大于等于1的整数；L代表单键或二价连接基团；Y3A代表酸性基团。
• [EN] PROCESS FOR THE HYDROCARBOXYLATION OF ETHYLENICALLY UNSATURATED CARBOXYLIC ACIDS<br/>[FR] PROCEDE DESTINE A L'HYDROCARBOXYLATION D'ACIDES CARBOXYLIQUES ETHYLENIQUEMENT INSATURES
  申请人：SHELL INT RESEARCH

  公开号：WO2004103942A1

  公开（公告）日：2004-12-02

  A process for the hydrocarboxylation of an ethylenically unsaturated carboxylic acid, by reacting it with carbon monoxide and a co-reactant selected from the group of water and carboxylic acids in the presence of a catalyst system including: (a) a source of palladium; (b) a bidentate diphosphine of formula (I), R1R2 > P - R3 - R - R4 - P < R5R6 (I) wherein P represents a phosphorus atom; R1, R2, R5 and R6 independently represent the same or different optionally substituted organic groups containing a tertiary carbon atom through which the group is linked to the phosphorus atom; R3 and R4 independently represent optionally substituted alkylene groups and R represents an optionally substituted aromatic group; (c) a source of anions derived from an acid having a pKa of less than 3, as measured at 18 °C in an aqueous solution.

  一种用于羰基化烯丙基不饱和羧酸的方法，通过在催化剂系统的存在下，将其与一氧化碳和来自水和羧酸组的共反应物反应，所述催化剂系统包括：(a) 钯源；(b) 公式(I)的双膦二齿配体，R1R2 > P - R3 - R - R4 - P < R5R6 (I)，其中P代表磷原子；R1、R2、R5和R6独立地代表相同或不同的可选择取代的有机基，通过该基与磷原子连接到含有三级碳原子的；R3和R4独立地代表可选择取代的烷基基团，R代表可选择取代的芳香基；(c) 源自具有pKa小于3的酸的阴离子的来源，该pKa值在18°C的水溶液中测定。
• [EN] CINNOLIN-4-AMINE COMPOUNDS AND THEIR USE IN TREATING CANCER<br/>[FR] COMPOSÉS CINNOLIN-4-AMINE ET LEUR UTILISATION POUR TRAITER LE CANCER
  申请人：ASTRAZENECA AB

  公开号：WO2017162605A1

  公开（公告）日：2017-09-28

  This specification generally relates to compounds of Formula (I). And pharmaceutically acceptable salts thereof, where R1, R2 and R3 have any of the meanings defined herein. The specification also relates to the use of such compounds and salts thereof to treat or prevent ATM kinase mediated disease, including cancer. The specification further relates to crystalline forms of compounds of Formula (I) and pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds and salts thereof; kits comprising such compounds and salts thereof; methods of manufacture of such compounds and salts thereof; intermediates useful in the manufacture of such compounds and salts thereof; and to methods of treating ATM kinase mediated disease, including cancer, using compounds of Formula (I) and salts thereof alone or in combination with other therapies.

  本规范通常涉及到式（I）的化合物，及其药用盐，其中R1、R2和R3具有本文中定义的任意含义。本规范还涉及使用这些化合物和其盐来治疗或预防ATM激酶介导的疾病，包括癌症。本规范还涉及到式（I）的化合物和其药用盐的结晶形式；包含这些化合物和其盐的药物组合物；包含这些化合物和其盐的试剂盒；这些化合物和其盐的制造方法；用于制造这些化合物和其盐的中间体；以及使用式（I）的化合物和其盐单独或与其他疗法结合治疗ATM激酶介导的疾病，包括癌症的方法。
• Some complexes of rhodium(I), rhodium(II), and rhodium(III) containing tertiary t-butylphosphines as ligands
  作者：C. Masters、B. L. Shaw

  DOI：10.1039/j19710003679

  日期：——

  Paramagnetic rhodium(II) complexes of the type trans-[RhCl2(PBut2R)2](R = Me, Et, or Prn) are formed rapidly by treating ethanolic rhodium(III) chloride trihydrate with the tertiary phosphine at 25 °C. The complexes have low magnetic moments in the solid state (<1·4 B.M.) but in solution trans-[RhCl2(PBut2Me)2] has the expected moment of ca. 2·12 B.M. Treatment of rhodium trichloride trihydrate with some t-butylphosphines

  反式-[RhCl 2（PBu t 2 R）2 ]（R = Me，Et或Pr n）型顺磁性铑（II）配合物可通过在叔膦中于3.0℃下用三水合氯化乙醇处理氯化铑（III）迅速形成。 25℃。配合物在固态（<1·4 BM）下具有较低的磁矩，但在溶液中反式-[RhCl 2（PBu t 2 Me）2 ]的预期磁矩为ca。2·12 BM用一些叔丁基膦处理三水合氯化铑（L = PBu t Pr n 2，PBu在回流的丙-2-醇中的t 2 Me，PBu t 2 Et或PBu t 2 Pr n）制得方形金字塔型氢化铑（III）络合物[RhHCl 2 L 2 ]。[RhHCl 2（PBu t Pr n 2） 2 ]与某些配体Q [Q = MeNC，MeCN，吡啶或P（OMe） 3 ]反应生成[RhHCl 2（PBu t Pr n 2） 2 Q ]。[RhHCl 2（PBu t 2 Me） 2 ]与氢气反应生成[RhH2